Clinical Trial Update: Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating supplementation with two probiotic strains reported reduced fasting triglycerides and increased apolipoprotein A-V levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• Dual probiotic strains (unspecified)

Snippet

Sponsor: Yonsei University | Conditions: Hypertriglyceridemia | Phase 3 | Status: COMPLETED